tripeptide antioxidant

Glutathione

US: FDA-approvedEU: Not on the registerUK: Not on the registerCA: AuthorisedAU: Status unknownCH: Not on the registerBR: RegistadoRS: Not on the registerSG: Not on the registerTR: Not on the register

Answer

Glutathione is authorised or registered in the US, Canada and Brazil: 3 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 276 registered trials, 44 of them running. Brand names on the FDA label register: Free Radical, Feelshion Dark Spot Remover Serum, Glutathione and Hepataplex.

RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03

Not medical, legal or regulatory advice.

Registered trials276Trial register ClinicalTrials.gov and EU CTIS
Running now44Trial register recruiting, active or enrolling
Results posted11Trial register with results on the register
Stopped early12%Trial register all peptides: 10%

276 trials by status

Trial register
Running 44Completed 153Stopped early 33Status unknown 38Other or not stated 8

ClinicalTrials.gov and EU CTIS · read 2026-10-03 · 11 trials have posted results

Trials first submitted per year

Trial register

ClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 128 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).

Status by jurisdiction

World map
Authorised or registeredNot on the register, or withdrawnNot read yet, or status unknown
WhereStatusRegisterRead
United StatesFDA-approvedFDA, openfda2026-10-03
European UnionNot on the registerEMA, ema2026-08-31
United KingdomNot on the registerMHRA, uk-mhra2026-09-03
CanadaAuthorisedHealth Canada, ca-dpd2026-10-03
AustraliaStatus unknownTGA, au-artgnot read
SwitzerlandNot on the registerSwissmedic, ch-swissmedic2026-09-03
BrazilRegistadoANVISA, br-anvisa2026-09-03
SerbiaNot on the registerALIMS, rs-alims2026-09-03
SingaporeNot on the registerHSA, sg-hsa2026-09-03
TurkeyNot on the registerTITCK, tr-titck2026-09-03

An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.

Side effects

Trial register
3 placebo-controlled trials · 146 people on Glutathione · grey is placebo
Neutrophil count decreased23.4% 18.7%
Anemia12.8% 16.5%
Peripheral sensory neuropathy12.8% 7.7%
Cough11.3% 10.7%
Fatigue10.6% 9.9%
ClinicalTrials.gov posted results · read 2026-10-03All side effects

CHANGE ALERTS

Get an email when this changes

One email when the status of Glutathione changes on the register. You confirm your address first.

ENFORCEMENT AND OFFICIAL ACTIONS

1 action by named authorities

Enforcement actions, board positions and payer rules that name Glutathione, quoted from the source document. These are not approval decisions. This list shows the actions found so far. It is not a complete list: no authority publishes one.

US-OHenforcement
Ohio Board of Pharmacy, 2026-04-16
During the inspection, [redacted] was found to possess multiple vials of the following illegal dangerous drugs, in either a white powder, purple powder, or clear liquid form, intended for injection, which were obtained from an unlicensed, foreign source: w. Glutathione 500mg, 5 vials;
State of Ohio Board of Pharmacy, Order, Case No. A-2026-0037, Findings of Fact paragraph 2(w) · quoted with the party redacted

REGISTERED TRIALS

Newest 10 of 276 trials

All 276 trials
NCT07304440
Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study
currently recruiting participants · register updated 2026-09-22
NCT04740580
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
running, but no longer enrolling · register updated 2026-09-09
NCT03493178
Glutathione in Mild Cognitive Impairment
running, but no longer enrolling · register updated 2026-09-04
NCT07792369
26DT052; Scaling Busulfan Dose to Body Surface Area in Children
not yet recruiting participants · register updated 2026-08-28
NCT07162623
Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on Subjects
completed · register updated 2026-08-06
NCT05654922
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
currently recruiting participants · register updated 2026-08-05
NCT07748507
Comparison of Gingival Depigmentation Using Microneedling and Microneedling With Glutathione Gel - A Split Mouth Clinical Trial
completed · register updated 2026-08-05
NCT07477275
Combination of Oral and Topical Whitening Agents for Reducing Skin Pigmentation
completed · register updated 2026-07-31
NCT04677972
SPI-1005 for the Treatment of Meniere's Disease
completed · register updated 2026-07-23
NCT07724067
GLUT-F Improves MASLD Liver Function
completed · register updated 2026-07-23

All peptides · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.